150 related articles for article (PubMed ID: 22241105)
1. BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis.
Julian-Reynier C; Fabre R; Coupier I; Stoppa-Lyonnet D; Lasset C; Caron O; Mouret-Fourme E; Berthet P; Faivre L; Frenay M; Gesta P; Gladieff L; Bouhnik AD; Protière C; Noguès C
Genet Med; 2012 May; 14(5):527-34. PubMed ID: 22241105
[TBL] [Abstract][Full Text] [Related]
2. Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: a qualitative study of patient preferences.
Hurley K; Rubin LR; Werner-Lin A; Sagi M; Kemel Y; Stern R; Phillips A; Cholst I; Kauff N; Offit K
Cancer; 2012 Dec; 118(24):6270-7. PubMed ID: 22736296
[TBL] [Abstract][Full Text] [Related]
3. Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners.
Gietel-Habets JJ; de Die-Smulders CE; Derks-Smeets IA; Tibben A; Tjan-Heijnen VC; van Golde R; Gomez-Garcia E; Kets CM; van Osch LA
Hum Reprod; 2017 Mar; 32(3):588-597. PubMed ID: 28073972
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer, BRCA mutations, and attitudes regarding pregnancy and preimplantation genetic diagnosis.
Woodson AH; Muse KI; Lin H; Jackson M; Mattair DN; Schover L; Woodard T; McKenzie L; Theriault RL; Hortobágyi GN; Arun B; Peterson SK; Profato J; Litton JK
Oncologist; 2014 Aug; 19(8):797-804. PubMed ID: 24951607
[TBL] [Abstract][Full Text] [Related]
5. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 mutation carriers have a lower number of mature oocytes after ovarian stimulation for IVF/PGD.
Derks-Smeets IAP; van Tilborg TC; van Montfoort A; Smits L; Torrance HL; Meijer-Hoogeveen M; Broekmans F; Dreesen JCFM; Paulussen ADC; Tjan-Heijnen VCG; Homminga I; van den Berg MMJ; Ausems MGEM; de Rycke M; de Die-Smulders CEM; Verpoest W; van Golde R
J Assist Reprod Genet; 2017 Nov; 34(11):1475-1482. PubMed ID: 28831696
[TBL] [Abstract][Full Text] [Related]
7. Hereditary breast and ovarian cancer and reproduction: an observational study on the suitability of preimplantation genetic diagnosis for both asymptomatic carriers and breast cancer survivors.
Derks-Smeets IA; de Die-Smulders CE; Mackens S; van Golde R; Paulussen AD; Dreesen J; Tournaye H; Verdyck P; Tjan-Heijnen VC; Meijer-Hoogeveen M; De Greve J; Geraedts J; De Rycke M; Bonduelle M; Verpoest WM
Breast Cancer Res Treat; 2014 Jun; 145(3):673-81. PubMed ID: 24748567
[TBL] [Abstract][Full Text] [Related]
8. Professionals assess the acceptability of preimplantation genetic diagnosis and prenatal diagnosis for managing inherited predisposition to cancer.
Julian-Reynier C; Chabal F; Frebourg T; Lemery D; Noguès C; Puech F; Stoppa-Lyonnet D
J Clin Oncol; 2009 Sep; 27(27):4475-80. PubMed ID: 19704065
[TBL] [Abstract][Full Text] [Related]
9. PGD for hereditary breast and ovarian cancer: the route to universal tests for BRCA1 and BRCA2 mutation carriers.
Drüsedau M; Dreesen JC; Derks-Smeets I; Coonen E; van Golde R; van Echten-Arends J; Kastrop PM; Blok MJ; Gómez-García E; Geraedts JP; Smeets HJ; de Die-Smulders CE; Paulussen AD
Eur J Hum Genet; 2013 Dec; 21(12):1361-8. PubMed ID: 23531862
[TBL] [Abstract][Full Text] [Related]
10. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
[TBL] [Abstract][Full Text] [Related]
11. BRCA1/2 pathogenetic variant carriers and reproductive decisions: Gender differences and factors associated with the choice of preimplantation genetic diagnosis (PGD) and prenatal diagnosis (PND).
Lombardi L; Trumello C; Stuppia L; Antonucci I; Brandão T; Babore A
J Assist Reprod Genet; 2022 Jul; 39(7):1433-1443. PubMed ID: 35661074
[TBL] [Abstract][Full Text] [Related]
12. Uptake of Preimplantation Genetic Diagnosis in Female BRCA1 and BRCA2 Mutation Carriers.
Mor P; Brennenstuhl S; Metcalfe KA
J Genet Couns; 2018 Dec; 27(6):1386-1394. PubMed ID: 29858758
[TBL] [Abstract][Full Text] [Related]
13. 'The BRCA clock is ticking!': negotiating medical concerns and reproductive goals in preimplantation genetic diagnosis.
Rubin LR; Werner-Lin A; Sagi M; Cholst I; Stern R; Lilienthal D; Hurley K
Hum Fertil (Camb); 2014 Sep; 17(3):159-64. PubMed ID: 25105219
[TBL] [Abstract][Full Text] [Related]
14. Reproductive Decision-Making in Women with BRCA1/2 Mutations.
Chan JL; Johnson LNC; Sammel MD; DiGiovanni L; Voong C; Domchek SM; Gracia CR
J Genet Couns; 2017 Jun; 26(3):594-603. PubMed ID: 27796678
[TBL] [Abstract][Full Text] [Related]
15. Reproductive decision-making in young female carriers of a BRCA mutation.
Donnelly LS; Watson M; Moynihan C; Bancroft E; Evans DG; Eeles R; Lavery S; Ormondroyd E
Hum Reprod; 2013 Apr; 28(4):1006-12. PubMed ID: 23293217
[TBL] [Abstract][Full Text] [Related]
16. Family planning in carriers of BRCA1 and BRCA2 pathogenic variants.
Haddad JM; Robison K; Beffa L; Laprise J; ScaliaWilbur J; Raker CA; Clark MA; Hofstatter E; Dalela D; Brown A; Bradford L; Toland M; Stuckey A
J Genet Couns; 2021 Dec; 30(6):1570-1581. PubMed ID: 33904624
[TBL] [Abstract][Full Text] [Related]
17. Performing and Declining PGD: Accounts of Jewish Israeli Women Who Carry a BRCA1/2 Mutation or Partners of Male Mutation Carriers.
Dagan E; Birenbaum-Carmeli D; Friedman E; Feldman B
J Genet Couns; 2017 Oct; 26(5):1070-1079. PubMed ID: 28265801
[TBL] [Abstract][Full Text] [Related]
18. Reproductive Decision-Making in MMR Mutation Carriers After Results Disclosure: Impact of Psychological Status in Childbearing Options.
Duffour J; Combes A; Crapez E; Boissière-Michot F; Bibeau F; Senesse P; Ychou M; Courraud J; de Forges H; Roca L
J Genet Couns; 2016 Jun; 25(3):432-42. PubMed ID: 26392361
[TBL] [Abstract][Full Text] [Related]
19. "My funky genetics": BRCA1/2 mutation carriers' understanding of genetic inheritance and reproductive merger in the context of new reprogenetic technologies.
Werner-Lin A; Rubin LR; Doyle M; Stern R; Savin K; Hurley K; Sagi M
Fam Syst Health; 2012 Jun; 30(2):166-80. PubMed ID: 22709328
[TBL] [Abstract][Full Text] [Related]
20. Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report.
Bernstein JL; Thomas DC; Shore RE; Robson M; Boice JD; Stovall M; Andersson M; Bernstein L; Malone KE; Reiner AS; Lynch CF; Capanu M; Smith SA; Tellhed L; Teraoka SN; Begg CB; Olsen JH; Mellemkjaer L; Liang X; Diep AT; Borg A; Concannon P; Haile RW;
Eur J Cancer; 2013 Sep; 49(14):2979-85. PubMed ID: 23706288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
